The effect of immunosuppressive drug rapamycin on regulatory CD4+CD25+Foxp3+T cells in mice.

[1]  K. Safranow,et al.  CD 4 + CD 25 high regulatory T cells and CD 4 + CD 69 + T cells in peripheral blood of patients with cutaneous lupus erythematosus , 2009 .

[2]  Christopher H Contag,et al.  Inhibition of CD4+CD25+ regulatory T-cell function by calcineurin-dependent interleukin-2 production. , 2006, Blood.

[3]  M. Kasai,et al.  Induction of regulatory T cells from mature T cells by allogeneic thymic epithelial cells in vitro , 2006, Transplant international : official journal of the European Society for Organ Transplantation.

[4]  S. Ziegler.  FOXP3: of mice and men. , 2006, Annual review of immunology.

[5]  M. Bevan,et al.  Central tolerance: good but imperfect , 2006, Immunological reviews.

[6]  T. Strom,et al.  Specificity of CD4+CD25+ Regulatory T Cell Function in Alloimmunity1 , 2006, The Journal of Immunology.

[7]  A. Rudensky,et al.  A function for interleukin 2 in Foxp3-expressing regulatory T cells , 2005, Nature Immunology.

[8]  S. Jameson,et al.  Central tolerance: learning self-control in the thymus , 2005, Nature Reviews Immunology.

[9]  F. Locatelli,et al.  Sirolimus-related toxicity in stem cell transplantation. , 2005, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

[10]  M. Battaglia,et al.  Rapamycin selectively expands CD4+CD25+FoxP3+ regulatory T cells. , 2005, Blood.

[11]  G. Mazariegos,et al.  Replacing calcineurin inhibitors with mTOR inhibitors in children , 2005, Pediatric transplantation.

[12]  S. Sakaguchi.  Naturally arising Foxp3-expressing CD25+CD4+ regulatory T cells in immunological tolerance to self and non-self , 2005, Nature Immunology.

[13]  Shimon Sakaguchi,et al.  Homeostatic maintenance of natural Foxp3 + CD25+ CD4+ regulatory T cells by interleukin (IL)-2 and induction of autoimmune disease by IL-2 neutralization , 2005, The Journal of experimental medicine.

[14]  M. Clement,et al.  LY294002 and rapamycin co‐operate to inhibit T‐cell proliferation , 2005, British journal of pharmacology.

[15]  H. Koenen,et al.  Tolerizing Effects of Co-stimulation Blockade Rest on Functional Dominance of CD4+CD25+ Regulatory T Cells , 2005, Transplantation.

[16]  S. Sakaguchi,et al.  Regulatory T Cells in Immunologic Self-Tolerance and Autoimmune Disease , 2005, International reviews of immunology.

[17]  S. Stevens,et al.  Dysfunctional Blood and Target Tissue CD4+CD25high Regulatory T Cells in Psoriasis: Mechanism Underlying Unrestrained Pathogenic Effector T Cell Proliferation1 , 2005, The Journal of Immunology.

[18]  A. Langnas,et al.  Altered allogeneic immune responses in middle-aged mice. , 2004, Cellular & molecular immunology.

[19]  C. Piccirillo,et al.  Cornerstone of peripheral tolerance: naturally occurring CD4+CD25+ regulatory T cells. , 2004, Trends in immunology.

[20]  M. Farrar,et al.  Distinct IL-2 Receptor Signaling Pattern in CD4+CD25+ Regulatory T Cells1 , 2004, The Journal of Immunology.

[21]  C. Benoist,et al.  Back to central tolerance. , 2004, Immunity.

[22]  C. Craddock,et al.  Chronic graft-versus-host disease is associated with increased numbers of peripheral blood CD4+CD25high regulatory T cells. , 2004, Blood.

[23]  S. Fu,et al.  CD4+ CD25+ CD62+ T‐Regulatory Cell Subset Has Optimal Suppressive and Proliferative Potential , 2004, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.

[24]  幸治 浦牛原.  Regulation of murine inflammatory bowel disease by CD25[+] and CD25[-]CD4[+] glucocorticoid-induced TNF receptor family-related gene[+] regulatory T cells , 2004 .

[25]  Catherine J. Wu,et al.  Sirolimus, tacrolimus, and low-dose methotrexate for graft-versus-host disease prophylaxis in mismatched related donor or unrelated donor transplantation. , 2003, Blood.

[26]  F. Ramsdell,et al.  An essential role for Scurfin in CD4+CD25+ T regulatory cells , 2003, Nature Immunology.

[27]  H. Bergmeister,et al.  The influence of immunosuppressive drugs on tolerance induction through bone marrow transplantation with costimulation blockade. , 2003, Blood.

[28]  A. Rudensky,et al.  Foxp3 programs the development and function of CD4+CD25+ regulatory T cells , 2003, Nature Immunology.

[29]  T. Nomura,et al.  Control of Regulatory T Cell Development by the Transcription Factor Foxp3 , 2002 .

[30]  S. Sakaguchi.  Immunologic Tolerance Maintained by Regulatory T Cells: Implications for Autoimmunity, Tumor Immunity and Transplantation Tolerance , 2002, Vox sanguinis.

[31]  Joshua Miller,et al.  A long-term comparison of tacrolimus (FK506) and cyclosporine in kidney transplantation: evidence for improved allograft survival at five years. , 2002, Transplantation.

[32]  M. Prystowsky,et al.  Rapamycin blocks IL-2-driven T cell cycle progression while preserving T cell survival. , 2001, Blood Cells, Molecules & Diseases.

[33]  R. Abraham,et al.  Immunopharmacology of rapamycin. , 1996, Annual review of immunology.

[34]  D. Fruman,et al.  Cyclosporin A and FK506: molecular mechanisms of immunosuppression and probes for transplantation biology. , 1993, Current opinion in immunology.